As of 2024-07-27, the Relative Valuation of Utah Medical Products Inc (UTMD) is 151.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 69.48 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 117.5%.
The range of the Relative Valuation is 133.07 - 169.39 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.9x - 36.5x | 36.2x |
| Forward P/E multiples | 32.3x - 32.9x | 32.6x |
| Fair Price | 133.07 - 169.39 | 151.15 |
| Upside | 91.5% - 143.8% | 117.5% |
| Date | P/E |
| 2024-07-26 | 14.97 |
| 2024-07-25 | 15.18 |
| 2024-07-24 | 16.17 |
| 2024-07-23 | 16.18 |
| 2024-07-22 | 15.64 |
| 2024-07-19 | 15.06 |
| 2024-07-18 | 15.30 |
| 2024-07-17 | 15.66 |
| 2024-07-16 | 15.51 |
| 2024-07-15 | 14.84 |
| 2024-07-12 | 14.79 |
| 2024-07-11 | 14.95 |
| 2024-07-10 | 14.51 |
| 2024-07-09 | 14.24 |
| 2024-07-08 | 14.29 |
| 2024-07-05 | 14.18 |
| 2024-07-03 | 14.30 |
| 2024-07-02 | 14.24 |
| 2024-07-01 | 14.35 |
| 2024-06-28 | 14.40 |
| 2024-06-27 | 14.40 |
| 2024-06-26 | 14.48 |
| 2024-06-25 | 14.45 |
| 2024-06-24 | 14.34 |
| 2024-06-21 | 14.42 |
| 2024-06-20 | 14.44 |
| 2024-06-18 | 14.31 |
| 2024-06-17 | 14.39 |
| 2024-06-14 | 14.39 |
| 2024-06-13 | 14.51 |
| 2024-06-12 | 14.41 |
| 2024-06-11 | 14.56 |
| 2024-06-10 | 14.54 |
| 2024-06-07 | 14.52 |
| 2024-06-06 | 14.51 |
| 2024-06-05 | 14.51 |
| 2024-06-04 | 14.74 |
| 2024-06-03 | 15.00 |
| 2024-05-31 | 14.72 |
| 2024-05-30 | 14.46 |
| 2024-05-29 | 14.65 |
| 2024-05-28 | 14.84 |
| 2024-05-24 | 14.44 |
| 2024-05-23 | 14.45 |
| 2024-05-22 | 14.50 |
| 2024-05-21 | 14.81 |
| 2024-05-20 | 14.84 |
| 2024-05-17 | 15.02 |
| 2024-05-16 | 15.18 |
| 2024-05-15 | 14.92 |